Multivariate Analysis of the Prognostic Significance of DNA-Ploidy and S-Phase Fraction in Ovarian Cancer Determined by Flow Cytometry Following Detection of Cytokeratin-Labeled Tumor Cells

By Kimmig R.   Wimberger P.   Hillemanns P.   Kapsner T.   Caspari C.   Hepp H.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 21-31

Elsevier

Access to resources Recommend Favorite

DNA Content and S-Phase Fraction in Epithelial Ovarian Cancer: What Information Do They Really Add?

By Braly P.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer

By Moureau-Zabotto L.  

Breast Cancer Research and Treatment, Vol. 91, Iss. 1, 2005-05 ,pp. : 61-71

Springer Publishing Company

Access to resources Recommend Favorite

Cell Proliferation in Ovarian Carcinoma: Superior Accuracy of S-Phase Fraction (SPF) by DNA Labeling Index versus Flow Cytometric SPF, Lack of Independent Prognostic Power for SPF and DNA Ploidy, and Limited Effect of SPF on Tumor Growth Rate

By Meyer J.S.   Gersell D.J.   Yim S.  

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 466-476

Elsevier

Access to resources Recommend Favorite

S-phase cell-specific modification by gemcitabine of PFGE-analyzed radiation-induced DNA fragmentation and rejoining

By Jensen Alexandra   Debus Jurgen   Weber Klaus-Josef  

International Journal of Radiation Biology, Vol. 84, Iss. 9, 2008-01 ,pp. : 770-777

Informa Healthcare

Access to resources Recommend Favorite